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Abstract
Background: Cardiac complication represents a major cause of morbidity and mortality after total joint arthroplasty,
thus necessitating investigation into the associated risks in total hip arthroplasty and total knee arthroplasty. There
remains a lack of clarity for many risk factors in the current literature. The aim of this systematic review is to assess
the most recent published literature and identify the risk factors associated with cardiac complication in total hip
arthroplasty and total knee arthroplasty.
Methods: Scopus, PubMed, CINHAL, and Cochrane were searched to identify studies published since 2008 reporting
on risk factors associated with cardiac complication in elective primary in total hip arthroplasty and total knee
arthroplasty in patients ≥18 years old with osteoarthritis. Reported odds ratios, hazard ratios, and relative risk were the
principal summary measures collected. The included studies were too heterogeneous to enable meta-analysis.
Results: Fifteen studies were included in this systematic review. Increasing age and history of cardiac disease were
found by most studies to be positively associated with risk of cardiac complication. There was no strong association
found between obesity and cardiac complication. The evidence for other risk factors was less clear in the examined
literature, although there is suggestive evidence for male gender and cerebrovascular disease increasing risk.
Conclusions: Increasing age and history of cardiac disease increases the risk of cardiac complication after total hip
arthroplasty and total knee arthroplasty. Other risk factors commonly attributed to increased risk in non-cardiac surgery
including hypertension and obesity require further evaluation in arthroplasty.
Systematic review registration: A detailed protocol was published in the PROSPERO database (registration number
CRD42018095887) for this systematic review.
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Introduction
Total hip arthroplasty (THA) and total knee arthroplasty
(TKA) is the definitive surgical treatment for osteoarthritis
(OA) of the hip and knee to improve quality of life, allevi-
ate pain, and enhance function [1–3]. It is predicted that
by 2030, there will be a 174% and 673% growth for THA
and TKA respectively, with a projected 4 million total
joint arthroplasties (TJA) annually in the USA [4–6].
Although TJA is considered a relatively safe procedure
with reported rates of major cardiac complication as low
as 0.2 to 0.8%, this risk becomes increasingly significant
when considering the substantial increase in arthroplasties
expected in the future [7–11]. Cardiac complication repre-
sents a major cause of morbidity and mortality after TJA
and is associated with increased hospital mortality, in-
creased length of stay, increased non-cardiac events,
and increased health expenditure [7, 12–15]. There-
fore, there is a growing imperative to understand the
risks contributing to cardiac complications associated
with THA and TKA.
With advances in medical care increasing life expect-
ancy combined with sedentary lifestyles, the TJA popula-
tion is increasing in age and comorbidity, particularly
obesity and diabetes [16–18]. This poses an evolving
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challenge in TJA; to navigate the increasing rate of
arthroplasty procedures in a population with greater car-
diovascular risk. In anticipation of this, there has been a
surge of literature in the last decade to identify patient
risk factors that predispose to cardiovascular complica-
tion. Nonetheless, there remains a lack of consensus and
clarity for many risk factors.
Previous systematic reviews have focussed on identify-
ing peri- and post-operative complications associated
with TJA [19–25]. Risk factors for one specific complica-
tion, venous thromboembolism, were discussed in a re-
view by Zhang et al. [19]; however, to the best of our
knowledge, there are no systematic reviews specifically
exploring the risk factors which contribute to major car-
diac complications in THA and TKA. Therefore, the
aim of this systematic review is to assess the most recent
published literature and identify the risk factors associ-
ated with cardiac complication in THA and TKA.
Materials and methods
Search strategy
This systematic literature review was performed in ac-
cordance with the preferred reporting items for system-
atic review and meta-analysis (PRISMA) guidelines (see
Additional file 1) [26]. Prior to commencing the study, a
detailed protocol was published in the PROSPERO data-
base (registration number CRD42018095887). Four data-
bases including Scopus, MEDLINE/PubMed, CINAHL,
and the Cochrane Library were searched on 13th of
May, 2018 for the following search terms: (heart OR
myocard* OR cardi*) AND (arthroplasty OR “joint re-
placement” OR “knee replacement” OR “hip replace-
ment”) AND (risk OR complication OR adverse OR
problem OR event OR issue OR mortality OR morbid-
ity) AND (factor* OR characteristic* OR predispos* OR
predic* OR profile). The following MeSH terms were
also included in our search: Arthroplasty, Cardiology,
Orthopaedics, and Risk Factors. Manual searches were
also performed through hand searching the reference
lists of included articles.
Study selection
This review included studies that explored specific risk
factors for cardiac complication associated with elective
primary THA and TKA in patients ≥18 years old. Stud-
ies involving other types of arthroplasty or concerning
revision THA or TKA were excluded. Only studies pub-
lished from 2008 onwards were considered, and studies
were excluded if more than 50% of their study popula-
tion were operated on prior to 2008. This review only
included studies in which the indication for TJA was
osteoarthritis and excluded those with fractures, inflam-
matory, or autoimmune disease (rheumatoid arthritis,
ankylosing spondylitis, psoriatic arthritis etc.). Studies
examining the risk of cardiac complication associated
with medication exposures, such as the use of
anti-thrombotic agents and beta-blockers prior to sur-
gery, were also excluded for the purpose of this analysis.
Cardiac complication was defined in this review as car-
diac arrest (CA), myocardial infarction (MI), or
new-onset arrhythmia, occurring within 90 days of THA
or TKA. Articles which reported on general outcomes
such as increased length of hospital stay or major com-
plication without exploring the specific associations be-
tween a risk factor and cardiac complication were
excluded. Literature that was not available in the English
language, studies involving animal models, and levels IV
and V evidence papers were also excluded.
Titles and abstracts were screened by two independent
investigators (YE, IJ), and following exclusions, full-text
articles were reviewed for eligibility. If two investigators
could not reach a consensus on inclusion, a third inves-
tigator (HL) was involved in the final determination.
Data extraction
Data extraction was performed using a pre-defined excel
spreadsheet, which was prepared and agreed upon by
three independent authors (YE, IJ, HL). Extracted data
included information on study characteristics, patient
demographics (age, gender, procedure) and comorbidi-
ties (cardiovascular and non-cardiovascular), as well as
incidence of cardiac complication in each study.
Reported odds ratios (OR), hazard ratios (HR), and rela-
tive risk (RR) were the principal summary measures col-
lected to determine the association between studied risk
factors and cardiac complication. Only significant values
will be reported in this review, with statistical signifi-
cance set as p < 0.05. Data on the definitions of cardiac
complication and the length of follow-up was also ex-
tracted. Where possible, sub-group analysis between
TKA and THA was collected to compare these cohorts
in the analysis. Following data extraction, the included
studies were too heterogeneous and therefore a
meta-analysis was not conducted.
Study quality assessment
A quality assessment tool was specifically developed for
this review based on two existing appraisal tools: the
Newcastle–Ottawa Scale and the Evidence-Based Library
Appraisal Checklist (Additional file 2: Table S1) [27, 28].
Our tool included 25 questions, which assessed study
methodology, population selection, diagnosis, and report-
ing of cardiac complications, as well as the level of analysis
between THA and TKA cohorts. Two authors (YE and IJ)
who were blinded from study identifiers (title, author, and
journal) conducted the quality assessment. Any discrepan-
cies of two or more points led to review by a third author
(HL) and discussion until consensus was achieved. All 25
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questions were equally weighted and individual scores
were calculated based on the number of ‘YES’ an-
swers. The final score was calculated as a percentage
of the number of answerable questions. Studies that
scored < 80%, 80–89%, and > 90% were deemed of
low, moderate, and high quality, respectively.
Results
Selection of included studies
The systematic search identified 2544 articles (Fig. 1).
Following removal of duplicates, 1809 articles remained
for screening. The majority of articles were excluded for
arthroplasty other than primary THA or TKA (revision,
shoulder, ankle, or elbow arthroplasty), indications other
than osteoarthritis, and studies primarily concerned with
infection or thrombo-embolic disease. Sixty-seven
full-text articles were evaluated; 33 were excluded be-
cause they did not report any association between risk
factors and cardiac complication, 9 included arthroplas-
ties other than primary TJA for osteoarthritis, 4 in which
> 50% of surgeries occurred prior to 2008, 3 for lack of
specific risk factor analysis, and 3 for follow-up times
beyond 90 days and population age outside of the inclu-
sion range (Fig. 1). A total of 15 articles were eligible for
inclusion in this systematic review, with a publication
range from 2014 to 2018.
Description of included studies
All studies included in this series were retrospective in
nature (Table 1) with the exception of Abdel et al.,
which utilised a prospective design [29]. Fourteen stud-
ies were classified as level III evidence, reflecting the
Fig. 1 PRISMA flowchart. A total of 2544 studies were evaluated for an association between patient risk factors and cardiac complication. Titles
and abstracts were assessed, and 67 full-text articles were eligible for evaluation. Fifty-two articles were excluded, and 15 articles remained for the
final systematic review
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majority of cohort studies, whilst one was level II [29].
Many of the studies derived their study population from
shared databases, such as the American College of Sur-
geons National Surgical Quality Improvement Program
(ACS NSQIP) database, National Inpatient Sample
(NIS), Medicare in-patient claims data, and other joint
registries. A total of 8 of 15 articles included both THA
and TKA study populations, 6 used TKA cohorts and 1
used THA (Table 1). Five studies included only unilat-
eral TJA, three included both unilateral and bilateral
procedures, and seven studies did not specify between
unilateral and bilateral procedures.
Seven studies followed patients for 30 days after TJA,
four included a 90-day postoperative follow-up period,
and four only reported in-hospital complications
(Table 1). MI was assessed by 14 studies, CA in 7, and
Table 1 Study characteristics
Year Country Range of
data set
Evidence
level
Data source Unilateral
vs. bilateral
Cardiac complication
studied
Follow-up
period
Main risk factors
studied
Single cohort (TKA or THA) studies
Fu [33] 2017 USA 2005–2 013 III NSQIP N/R CA or MI 30 days BMI and albumin
concentration
Curtis [32] 2018 USA 2008–2014 III NSQIP N/R CA or MI 30 days Heart failure
Chamieh [35] 2016 USA 2008–2012 III NSQIP Unilateral CA or MI 30 days Pre-operative
anaemia
Godoy [31] 2016 USA 2013–2015 III Oschsner Clinic Unilateral MI or arrhythmia 90 days Pre-operative ESR
and CRP levels
Abdel [29] 2014 USA 2007–2010 II Joint Replacement
Registry
Unilateral MI I/H BMI
Meller [34] 2016 USA 2011–2013 III Medicare inpatient
claims
Unilateral
and bilateral
MI 90 days BMI
Mellerγ [17] 2016 USA 2010–2014 III Medicare
inpatient claims
Unilateral
and bilateral
MI 90 days BMI
Combined (THA and TKA) cohorts
Waterman [12] 2016 USA 2012–2013 III NSQIP Unilateral MI and CA
(requiring CPR)
30 days Age, hypertension
and cardiac
disease
Robinson [6] 2017 USA 2012–2013 III NSQIP N/R MI or CA 30 days Gender
Feng [4] 2018 China 2005–2015 III Hospital Joint
Arthroplasty
Registry
Unilateral
and bilateral
MI or arrhythmia 30 and
90 days
Coronary artery
disease and
revascularisation
Thornqvist [8] 2014 Denmark 2005–2011 III Danish National
Patient Register
and Danish
Anaesthesia
Register
N/R MI or cardiac
mortality
30 days BMI
Menendez [11] 2015 USA 2008–2011 III NIS N/R MI I/H Elixhauser
comorbidity index
variables and CAD,
COPD, CVA,
dementia
Shah [7] 2017 USA 2011–2014 III NSQIP N/R MI or CA 30 days TKA and THA
Belmont [5] 2014 USA 2006–2011 III NSQIP Unilateral MI or CA 30 days Many medical
comorbidities and
patient
characteristics
Anoushiravani [30] 2016 USA 2006–2012 III NIS N/R Cardiac
complications
I/H Underweight
patients
Study characteristics were collected for each included study, including publication year, country of origin, and data source. Unilateral procedures were
distinguished from bilateral procedures when possible and the period of follow-up post-operatively specified. The range of data set encompasses the period in
which included arthroplasty procedures were performed, and the specific cardiac complication studied was also included. CA cardiac arrest, MI myocardial
infarction, CPR cardiopulmonary resuscitation, BMI body mass index, N/R not reported, NSQIP National Surgical Quality Improvement Program database, NIS
Nationwide Inpatient Sample, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, CVA cerebrovascular disease, I/H in-hospital follow up
(prior to discharge). γ = This is the only single cohort study that examined THA; the remainder of single cohort studies consisted of TKA
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arrhythmia in only 2. Authors in one study [30] did not
specify which cardiac complication they evaluated. Risk
factors evaluated by the included studies included modi-
fiable and non-modifiable patient factors, comorbidities,
and surgery type (Table 1).
Across the 15 studies, study populations ranging in age
between 18 and > 85 years old were included; most studies
reported an average age of mid-to-late 60s (Table 2). The
total number of study participants cannot be accurately
identified due to a high likelihood of duplicate study pop-
ulations. In 13 studies, TJA cohorts were predominated by
the female gender (Table 2), whilst two studies did not
provide gender-specific information of the total cohort in
their primary text [5, 31]. The most common arthroplasty
procedure in this series was TKA, with the exception of
two studies [17, 30].
Risk of bias of the included studies
The inter-observer agreement on the quality of included
studies ranged between 90 and 100%. Out of 15 articles
included in this review, only 2 were deemed high quality,
11 were moderate quality, and 2 were low quality ac-
cording to the appraisal tool used (Additional file 2:
Table S1). Study quality was mainly limited by the use of
study populations derived from large shared databases,
the lack of specificity surrounding TJA details (indica-
tion, unilateral vs. bilateral), and failure to discuss defini-
tions of the studied cardiac complication in relation to
an accepted guideline.
Association between risk factors and cardiac complication
The incidence of cardiac complication ranged from 0.07
to 3.0% across the studies [4, 7]. Several comorbidities
Table 2 Study demographics
Author Total number of participants Age range (years) Female (%)
Single cohort (TKA or THA) studies
Fu [33] 34,800 18 to > 80 63.2%
Curtis [32] 111,624 N/R Control 63%
Heart failure 55%
Chamieh [35] 41,334 18 to > 80 No anaemia 64.1%
Any anaemia 62.5%
Godoy [31] 317 40 to 91 N/R
Abdel [29] 4718 Not specified Obese 65.7%
Non-obese 54%
Meller (TKA) [34] 585,127 65 to > 85 Normal weight 62%
Morbidly obese 75%
Super obese 82%
Meller (THA) [17] 432, 841 65 to > 85 Normal 62%
Morbidly obese 68%
Super obese 77%
Combined cohort (TKA and THA) studies
Waterman [12] 34,066 N/R TKA 63%
THA 56%
Robinson [6] 54,502 18 to > 75 TKA 62.3%
THA 54.9%
Feng [4] 4414 38 to 82 72%
Thornqvist [8] 34,744 59 to 82 59%
Menendez [11] 3,096,791 < 45 to > 85 No AMI 60.5%
AMI 49.5%
Shah [7] 45,943 N/R THA 49%
TKA 53%
Belmont [5] 46,322 N/R THA + THA 60.5%
Anoushiravani [30] 4865 N/R THA
Normal 85.7%
Underweight 85.3%
TKA
Normal 78.0%
Underweight 78.5%
The number of participants in each study was included; however, it was not possible to calculate the total number of participants across studies due to a high
likelihood of duplicate studies (since many studies used similar databases). In the majority of studies, an age range of the study participants was specified; study
populations ranging between 18 and > 85 years old were included in this review. Female gender formed the majority of participants across most study groups.
N/R not reported; AMI acute myocardial infarction
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were investigated for an association with cardiac compli-
cation in THA and TKA. Age, gender, type of arthro-
plasty, history of cardiac disease, hypertension, chronic
pulmonary disease, diabetes, and obesity were thor-
oughly evaluated in our series (Table 3). Other risk fac-
tors including renal failure, malnutrition, anaemia,
alcohol abuse, cerebrovascular disease, and smoking his-
tory were discussed, though reported to a lesser extent
(Table 3).
Age
Six studies reported on the relationship between age
and cardiac complication (Additional file 3: Table S2)
[4, 5, 7, 8, 11, 12]. For age ≥ 80 years, both Waterman
et al. and Belmont Jr. et al. reported increased odds of
cardiac complication in both TKA (OR 1.85; 95% CI
1.23–2.79; p = 0.003 and OR 27.95; CI 95% 2.01–388.93;
p = 0.0016, respectively) and THA (OR 4.39; 95% CI
2.29–6.61; p < 0.001 and OR 3.72; CI 95% 1.53–9.06; p
= 0.0001, respectively) [5, 12]. Menendez et al. similarly
reported an increased risk for patients aged 45–64 (OR
4.4; CI 95% 2.6–7.4; p < 0.001), 65–84 (OR 6.5; CI 95%
3.8–11.0; p < 0.001), and > 85 (OR 9.4; CI 95% 5.5–16.1;
p < 0.001) [11]. Conversely, Feng et al. did not show any
association between age and cardiac complication
(Additional file 3: Table S2) [4].
Gender
The influence of gender on the risk of cardiac complica-
tion in TJA was also assessed in six studies
(Additional file 3: Table S2) [4–8, 11]. Robinson et al.
found that female gender was a protective factor for
myocardial infarction in both THA (OR 0.54; 95% CI
0.40–0.75; p < 0.001) and TKA (OR 0.59; 95% CI 0.45–
0.76; p < 0.001) [6]. In contrast, male gender was associ-
ated with increased risk of MI in THA (OR 1.84; 95% Cl
Table 3 Number of studies examining each risk factor and the proportion of positive, negative, and insignificant associations found
Risk factors Studies reporting on a risk factor for cardiac complication after THA or TKA
N p≤ 0.05 p > 0.05
+ − ~
Age 6 4 − 2
Male 6 2 − 4
Female 6 – 1 4
TKA 4 1 − 2
THA 4 2 − 2
Unilateral − – − −
Bilateral 1 1 − −
History of cardiac disease 5 4 − 1
CHF 4 2 − 2
Valvular disease 1 1 − −
PVD 3 1 − 2
CAD 3 2 − 1
Hypertension 4 2 1 1
Chronic pulmonary disease 4 – 1 3
Diabetes 4 2 − 2
Renal failure 4 1 − 3
Obesity 8 1 − 7
Malnutrition 1 1 − −
Anaemia 3 1 − 2
Alcohol abuse 1 − 1 −
CVD 4 2 − 2
Smoking history 1 1 − −
ASA score > 2 2 1 − 1
The number of studies examining each risk factor and their association with cardiac complication in THA and TKA, and the number which showed a significant
(p ≤ 0.05) positive and negative association. Studies, which studied a given risk factor but did not show any significant association (p > 0.05), are also identified.
CHF congestive heart failure, PVD peripheral vascular disease, CAD coronary artery disease, CVD cerebrovascular disease, ASA American Society of
Anaesthesiologists. N number of studies examining this risk factor; + studies showing a positive and significant association; − studies showing a negative,
significant association; ~ insignificant result
Elsiwy et al. Journal of Orthopaedic Surgery and Research           (2019) 14:15 Page 6 of 12
1.34–2.52; p < 0.001) and TKA (OR 1.71; 95% Cl 1.31–
2.22; p < 0.001). Menendez et al. noted similar findings for
male gender as a risk (OR 1.4; CI 95% 1.4–1.5; p < 0.001)
[11]. Feng et al., Shah et al., and Belmont Jr. et al. did not
find a statistically significant predictive value of gender for
cardiac complication post-TJA (Additional file 3: Table S2)
[4, 5, 7].
History of cardiac disease
Seven articles explored the relationship between a his-
tory of cardiac disease and post-operative cardiac com-
plication [4, 5, 7, 8, 12, 32], with all seven reporting a
positive association (Additional file 4: Table S3). The
strongest association was shown by Feng et al. who
found that a history of MI was associated with a signifi-
cantly increased odds ratio for cardiac complication fol-
lowing TJA (15.1, 95% Cl 4.1–56.3; p < 0.001) [4].
Congestive heart failure and coronary artery disease
were found to be predictive risk factors for cardiac com-
plication in two studies [11, 32], with the study by
Menendez et al. also identifying an association with per-
ipheral vascular and valvular disease (Additional file 4:
Table S3) [11].
Obesity
Of 15 articles in this series, 8 investigated the effect of
obesity on cardiac complication post-TJA (Additional file
4: Table S3) [4, 7, 8, 17, 29, 30, 33, 34]. Feng et al. re-
ported that study participants with BMI ≥ 30 were at
greater risk of cardiac complication (OR 2.477; Cl 95%
1.17–5.21; p = 0.017) [4]. None of the other seven studies
demonstrated a statistically significant relationship be-
tween obesity and cardiac complication associated with
THA and TKA (p > 0.05). Conversely, Anoushiravani et
al. and Thornqvist et al. suggested a possible relationship
between underweight patients undergoing TJA and car-
diac complication; however, a p value was not reported
(Additional file 4: Table S3) [8, 30].
Hypertension
The effect of hypertension on risk of cardiac complication
was analysed in four studies (Additional file 3: Table S2)
[5, 7, 11, 12]. Belmont Jr. et al. reported statistically signifi-
cant associations for both TKA (OR 4.74; CI 95% 1.04–
21.59; p = 0.044) and THA (OR 2.59; CI 95% 1.07–6.23;
p = 0.0341) [5]. Similar findings were demonstrated by
Waterman et al. for TKA (OR 2.14; 95% CI 1.30–3.52;
p = 0.003) and THA (OR 1.82; 95% CI 1.09–3.03; p =
0.02) [12]. In contrast, Menendez et al. found that
hypertension was not associated with increased risk of
cardiac complication (OR 0.9; CI 95% 0.8–1.0; p =
0.003) [11], whilst Shah et al. similarly found no effect
for this risk factor (Additional file 3: Table S2) [7].
Diabetes
Four studies examined an association between dia-
betes and cardiac complication (Additional file 3:
Table S2) [5, 7, 8, 11]. Belmont Jr. et al. found that
for TKA, diabetes was positively associated with
post-operative cardiac complications (OR 2.62; CI
95% 1.41–4.87; p = 0.0023); however, the results were
not significant for THA [5]. Menendez et al. dis-
cussed cardiac complication in relation to complicated
and uncomplicated diabetes, with both shown to be asso-
ciated (OR 1.1; CI 95% 1.1–1.2; p < 0.001 and OR 1.2; CI
95% 1.0–1.3; p < 0.04, respectively) [11]. No relationship
between diabetes and cardiac complication was found by
Shah et al. (Additional file 3: Table S2) [7].
Type of arthroplasty (THA vs. TKA)
Differences between THA and TKA in relation to cardiac
complication were examined in four of the studies
(Additional file 3: Table S2) [4, 7, 8, 11]. In comparison to
TKA, Menendez et al. showed that THA was a better pre-
dictor for post-operative cardiac complication (OR 1.3; CI
95% 1.3–1.4; p < 0.001) [11]. Shah et al. found increased
risk of MI and CA in both THA and TKA populations
compared with knee arthroscopy controls (OR 2.61; CI
95% 1.46–4.69; p = 0.001 and OR 1.98; CI 95% 1.08–3.62;
p = 0.03, respectively) (Additional file 3: Table S2) [7].
Other risk factors
Feng et al. found no difference in cardiac complication
risk for TKA and THA, although the authors did identify
simultaneous bilateral procedures as a greater predictor of
cardiac events than unilateral arthroplasty (OR 1.57; Cl
95% 1.074–2.294; p = 0.02) (Additional file 4: Table S3)
[4]. Whilst one study reported an odds ratio of 1.1 (CI
95% 1.0–1.2; p < 0.006) for the association between renal
failure and cardiac complication [11], Shah et al. and
Belmont Jr. et al. found no significant association
(Additional file 3: Table S2) [5, 7]. Four studies examined
the effect of cerebrovascular disease; however, only two
studies demonstrated statistically significant results [5, 7,
8, 11]. Menendez et al. and Belmont Jr. et al. concluded
that cerebrovascular disease increased the risk of post-TJA
cardiac complication (OR 2.3; CI 95%, 2.0–2.6; p < 0.001
and OR 2.20; CI 95% 1.02–4.75; p = 0.0441 [THA popula-
tion], respectively) (Additional file 4: Table S3). Four
studies also examined chronic pulmonary disease as a risk
factor for cardiac complication [5, 7, 8, 11]. Menendez
et al. reported an odds ratio of 0.8 (CI 95% 0.7–0.8; p <
0.001) for an acute MI, whereas Shah et al. and
Belmont et al. did not show an association (Additional
file 3: Table S2). Malnutrition, defined as an albumin
level < 3.5 g/dL, and adjusted for BMI, was associated
with greater risk of cardiac complication in the study
by Fu et al. (OR 2.23; CI 95% 1.21–4.12; p = 0.010) [33].
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Out of three studies examining anaemia and cardiac
complication, only Menendez et al. showed statistical
significance (OR 1.4; CI 95% 1.3–1.5; p < 0.001) [5, 11,
35]. Smoking history was only examined by Shah et al.
who found a significant association with cardiac com-
plication in a THA population (OR 2.56; CI 95% 1.34–
4.91; p = 0.005) [7]. Finally, of the two studies that
employed the American Society of Anesthesiologists
(ASA) scoring system, only Shah et al. demonstrated an
association [5, 7]. In their analysis of the effect of ASA
3 to 4 in both THA and TKA, only the TKA population
was significantly predictive of cardiac complication (OR
2.47; CI 95% 1.28–4.74; p = 0.007) [7].
Discussion
The projected rise in hip and knee arthroplasty in the
next decade has emphasised the importance in under-
standing the risks and complications associated with
these procedures [4–6]. Myocardial infarction, cardiac
arrest, cerebrovascular accidents, deep vein thrombosis,
pulmonary embolism, and acute renal failure are major
complications known to be associated with THA and
TKA [36, 37]. Whilst current literature has extensively
evaluated and identified peri- and post-operative compli-
cations that can be expected with TJA, there is an overall
lack of evidence regarding patient risk factors associated
with development of complications, in particular, cardiac
complications. A previous systematic review identified
risk factors associated with venous thromboembolism in
TJA; however, the study by Zhang et al. did not specific-
ally investigate post-operative cardiac complication,
therefore necessitating this review [19]. A thorough un-
derstanding of these risk factors will allow for better
pre-operative care to reduce the incidence of cardiac
complication in TJA. The reasons for limiting this sys-
tematic review to studies published in 2008 and on-
wards, as well as those with at least 50% of surgeries
occurring since 2008 are two-fold. Firstly, significant
improvements in surgical techniques [25, 38, 39], im-
plant technology [39, 40], peri-operative [41] and
post-surgical management [40], changes in anaesthetic
practices [42–45], and the introduction of ‘fast-track’ hip
and knee arthroplasty [42, 44, 46] and same-day bilateral
arthroplasty have occurred over the past decade [47].
Secondly, THA and TKA are increasingly performed in
older patients as life expectancy increases [14, 39, 41], and
those with a greater burden of medical comorbidities in-
cluding obesity, diabetes, and hypertension [5, 43, 48].
Thus, we focused our investigation to the past decade
in order to comprehensively assess current cardiac
complications in THA and TKA and relationships to
patient risk factors.
In our series, Shah et al. reported the lowest incidence
of cardiac complication (0.07%), within a patient group
containing no reported risk factors [7]. Conversely, Feng
et al. reported the highest complication rate of 3.0%,
which is likely attributable to their study population,
which contained a greater proportion of coronary artery
disease patients [4]. The majority of studies reported in-
cidences of cardiac complication between 0.2 and 0.8%,
which is similar to that previously reported in the litera-
ture [7]. Of the risk factors analysed, age and history of
cardiac disease demonstrated the most consistent rela-
tionship with cardiac complication following THA or
TKA. The majority of studies examined in the current
review reported a positive association with these risk fac-
tors and peri- and post-operative cardiac complication
(Additional files 3 and 4: Tables S2 and S3) [4, 5, 7, 11,
12, 32]. This highlights the importance of age and his-
tory of cardiac disease in the pre-operative screening of
THA and TKA patients. Obesity was not identified as a
risk factor for cardiac complication post-TJA in this series
[7, 17, 29, 33, 34]. These findings are of interest to ortho-
paedic surgeons who are anticipating a more obese patient
demographic for arthroplasty in the future [29, 49].
Interestingly, we report a potential relationship between
cardiac complication and underweight patients [8, 30],
which warrants further investigation. For additional,
lesser-reported risk factors that were analysed in the
current review (i.e., bilateral arthroplasty, renal failure,
cerebrovascular disease, anaemia, smoking history, and
ASA class), the reviewed literature suggests some associ-
ation. As many of these factors are well-established risk
factors for cardiac complication following non-cardiac
surgery [50], further research will be necessary to better
determine these associations following THA and TKA.
Findings were less clear for other highly reported risk
factors such as gender, hypertension, diabetes, and type
of arthroplasty, due to greater discrepancy between stud-
ies. These inconsistencies were surprising given that
gender, hypertension, and diabetes are considered clas-
sical cardiovascular risk factors in non-cardiac surgery
[13, 50]. For diabetic patients, previous studies have also
reported a statistically significant increased risk of MI
following arthroplasty; however, these did not meet the
inclusion criteria for this review [18, 51]. The inconclu-
sive results in the current review with respect to these
particular risk factors may reflect the changes and im-
provements in arthroplasty previously mentioned, and/
or improved management of these risk factors, particu-
larly diabetes and hypertension. However, further inves-
tigation is required to better understand the factors
contributing to these variances.
Our findings must be considered in the context of the
quality of the included studies, together with the wider
literature. As evidenced by the results of our appraisal
tool (Additional file 2: Table S1), the majority of studies
in this series were of moderate quality and multiple
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limitations were identified that potentially contributed to
the discrepancies in results between studies. A com-
monly encountered limitation in this series was the lack
of consistency in study design. For example, although
Shah et al. identified significant associations, their study
design must be carefully considered for accurate inter-
pretation of data. A knee arthroscopy (KA) population
was used as a control cohort with the presumption that
KA is a lower risk treatment alternative for osteoarth-
ritis. However, this view is controversial in the current
literature [7]. Similarly, in their study of BMI and cardiac
complication, Thornqvist et al. included overweight pa-
tients (BMI 25 to 30) as a reference for all analysis [8],
rather than patients within a normal BMI range as is
typically used in the literature. Additionally, although
Thornqvist et al. and Anoushiravani et al. report a possible
relationship between underweight patients and the risk of
cardiac complication in TJA, accurate interpretation is im-
paired by the absence of a reported p value [8, 30]. Fur-
thermore, many of the studies used shared databases, such
as the NSQIP and the NIS. Whilst these databases have
allowed access to a large volume of data and assisted in
developing established pre- and post-operative risk strati-
fications models, there are limitations when used for ana-
lyses. For example, the NSQIP only includes data to 30
days after a surgical procedure and contains limited infor-
mation regarding several comorbidities [52]. Similarly, the
NIS only records inpatient events, does not allow for lon-
gitudinal tracking of patients, and does not facilitate dis-
tinction between comorbidities from complications [52].
In light of this, not all cardiac events would be identified
by studies in this series and some risk factors may be un-
accounted for.
To reduce the confounding effect of other disease pro-
cesses (e.g. rheumatoid arthritis), this review excluded
studies that grouped both OA and non-OA patients with-
out adequate sub-analysis. Despite this, all studies included
in our series, except four [4, 29, 32, 33], did not specify an
indication for TJA and therefore the effect of cofounders
cannot be accurately considered. This influences the reli-
ability of the results, which may not adequately reflect the
interaction between particular risk factors and cardiac
complication. Similarly, many studies did not distinguish
between unilateral or bilateral arthroplasty despite differ-
ent risk profiles of these two procedures [53]. This lack of
specificity is a shortcoming of the studies in this series, as
well as the current broader literature. Moreover, due to the
reliance on national databases for studies in this review,
few studies defined their cardiac outcomes (MI, CA, or
arrhythmia) to ensure consistency with the current guide-
lines. Across the various studies, risk factors and outcomes
were either poorly defined or defined differently, which
contributed to the heterogeneity of the data set and diffi-
culty of conducting a reliable comparative analysis [33].
Additional issues were identified in the broader litera-
ture with respect to the effects of many risk factors on
peri- and post-operative outcomes. The primary concern
encountered with these studies was a lack of further ana-
lysis to identify which risk factors were associated with a
given complication. This lack of detailed investigation is
unfortunate, particularly since in many cases the necessary
data was available. Many full-texts that were excluded dis-
cussed the relationship between risk factors and increased
hospital re-admission, length of stay, major complication
or mortality with little or no reference to the individual
complications. Although the findings of the current review
will help surgeons better understand the risks for patients
undergoing TJA, will assist pre-operative counselling of
patients, and will allow for better hospital resource alloca-
tion, the data does not provide sufficient guide for stratify-
ing patients at greater risk of cardiac complication. It is
crucial that future studies provide more robust analysis in
order to better determine the association between patient
risk factors and post-arthroplasty cardiac complications.
Future studies should also investigate various combina-
tions of risk factors, rather than analysing each factor as
an independent variable.
One of the major limitations of the current review is
the exclusion of potentially relevant studies and risk
factors due to the stringent inclusion/exclusion criteria
utilised. However, this was necessitated by the lack of
specificity in the current literature. Other important
risk factors not included in this series include obstruct-
ive sleep apnoea and atrial fibrillation. In a study of
530,809 patients, Memtsoudis et al. showed that sleep
apnoea was associated with greater odds of cardiac com-
plication (adjusted OR 1.59; CI 95% 1.48–1.71; p < 0.001)
[54]. With an increasing prevalence of sleep apnoea, this
is an important area of future research [54, 55]. Chronic
kidney disease has also been shown to be a significant pre-
dictor of cardiac complication (OR 5.5; CI 95% 1.68–9.39;
p = 0.002), as has atrial fibrillation (OR 2.4; CI 95% 2.1–
2.8; p < 0.0046) [56, 57]. Therefore, it is evident that, whilst
this systematic review provides an extensive evaluation on
the current literature, there are several other relevant
studies, which did not meet our inclusion criteria. The ex-
clusion of foreign language studies constitutes a language
bias in this review, whilst there is a potential selection bias
for studies utilising the large patient databases. Further-
more, publication bias resulting in only significant results
being published and/or being published earlier may result
in an over-representation of significant associations be-
tween risk factors and cardiac complications.
Recommendations
With the exception of age and history of cardiac disease, it
is apparent that additional risk factors for cardiac compli-
cations following TKA and THA require further
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investigation. Future studies should ensure risk factors,
and cardiac complications are defined consistently and
measured using validated tools. Currently, the majority of
the studies available in the current literature are retro-
spective in nature. More prospective studies may facilitate
better designed cohorts, avoiding the limitations of larger
databases and allowing for better conformity among stud-
ies. Lastly, for the literature to be applicable to the risk
stratification of TKA and THA patients, there is an im-
perative for more targeted studies that specifically attempt
to link risk factors to a cardiac complication (e.g. MI, CA,
or arrhythmia). Ultimately, data from such studies can
contribute to the development of pre-operative risk strati-
fication models that allow for pre-operative optimisation,
and therefore, fewer cardiac complications. Whilst Water-
man and colleagues have already attempted this success-
fully, other risk factors should be further evaluated to
make for a more comprehensive predictive tool [12].
Conclusion
As the rates of THA and TKA continue to rise, a
greater understanding about the risk factors for car-
diac complication is necessary. From this systematic
review, older age, and history of cardiac disease can
be considered as the most consistently reported risk
factors for cardiac complication in the current litera-
ture. Interestingly, this review suggests that obesity
may not increase the risk of cardiac complication;
however, more robust analysis is required. The
current literature is inconclusive for other important
risk factors, including diabetes, hypertension, gender,
and history of smoking, and these therefore require
further investigation. More comprehensive, targeted
data can be achieved by using specifically tailored co-
horts in which confounders, including arthroplasty in-
dication, unilateral vs. bilateral, and cemented vs.
non-cemented prostheses, are adequately controlled
for. Ultimately, this data can be used in the develop-
ment of an extensive pre-operative risk assessment
tool that can guide cardiology intervention to minim-
ise cardiac complication post-THA and TKA.
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